CD4 and lung adenocarcinoma: A study has found that there were more CD3+, CD4+, CD8+, and PD-1+ T cells in the peripheral blood of lung adenocarcinoma patients with long-term survival, indicating that the infiltration degree of immune cells in the tumor immune microenvironment is closely related to long-term survival [22].